Glass Jacobson Investment Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$387 Hold
1
﹤0.01% 598
2026
Q1
$293 Buy
+1
New +$329 ﹤0.01% 594
2025
Q3
Sell
-100
Closed -$38.9K 589
2025
Q2
$38.9K Buy
100
+80
+400% +$32.2K 0.02% 315
2025
Q1
$7.38K Hold
20
﹤0.01% 629
2024
Q4
$7.38K Buy
20
+4
+25% +$1.67K ﹤0.01% 629
2024
Q3
$8.32K Hold
16
﹤0.01% 583
2024
Q2
$8.67K Hold
16
﹤0.01% 569
2024
Q1
$8.3K Hold
16
﹤0.01% 576
2023
Q4
$7.54K Sell
16
-3
-16% -$1.39K ﹤0.01% 546
2023
Q3
$8.27K Buy
19
+1
+6% +$454 ﹤0.01% 515
2023
Q2
$8K Buy
+18
New +$8.3K ﹤0.01% 529
2022
Q4
$9.23K Buy
+18
New +$9.14K ﹤0.01% 526

Other funds holding ELV

Glass Jacobson Investment Advisors's ELV Position: Q2 2026 in Review

Glass Jacobson Investment Advisors held its Elevance Health (ELV) position steady in Q2 2026 at 1 share worth $387. The position accounts for ﹤0.01% of the portfolio, ranked #598.

Glass Jacobson Investment Advisors first reported a position in ELV in Q4 2022 and has held it in 12 quarters since. The position peaked at $38.9K in Q2 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Glass Jacobson Investment Advisors held 1 share of Elevance Health worth $387 as of Q2 2026.
  • Glass Jacobson Investment Advisors left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up ﹤0.01% of Glass Jacobson Investment Advisors's portfolio in Q2 2026, its #598 holding.
  • Glass Jacobson Investment Advisors first reported a position in Elevance Health in Q4 2022 and has held it in 12 quarters since.
  • Glass Jacobson Investment Advisors's Elevance Health position peaked at $38.9K in Q2 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Glass Jacobson Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.